Welcome
Support Centre
30 July 2010 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The psychological effects of completing daily diary dards for patients receiving chemotherapy
Source of recordUK Trials
ISRCTNISRCTN82960239
Date ISRCTN assigned30/09/2004
Local reference number(s)N0255127859
Public titleThe psychological effects of completing daily diary dards for patients receiving chemotherapy
Scientific title
AcronymN/A
Disease/condition/study domainSigns and Symptoms: Nausea and vomiting
Study hypothesisThere is a relationship between the use of daily diary cards and an increase in the incident of nausea/vomiting and anxiety in patients receiving chemotherapy
Design/methodologyRandomised controlled trial
Research ethics reviewNo ethics information provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaPatient recieving chemotherapy and using daily diary cards.
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date08/09/2003
Anticipated end date08/10/2004
Status of trialCompleted
Target number of participants68
InterventionsRandomised Controlled Trial - Qualitative and Quantitative.

The sample size calculation is based upon RSCL normative data for chemotherapy patients provided in the manual (De-Hanes eta al 1996). This information was not available within the literature for the HAD scale therefore it was decided to base the sample size on RSCL characteristics. Using the normative data from the RSCL manual I assumed: control group mean = 25; standard deviation = 22; treatment group standard deviation = 22. Based on these assumptions and requiring a statistical power of 0.8; using a 2-sided test at alpha = 0.05 to discern a 15 point difference between treatment and control groups the calculations indicated a sample size of 34 patients per group (total 68) would be sufficient.
Primary outcome measure(s)1. Hospital Anxiety and Depression (HAD) questionnaire
2. Rotterdam Symptom CheckList (RSCL)
3. Diary cards
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingThe Princess Alexandra Hospital NHS Trust (UK)
Sponsor nameRecord Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMs Noreen Cushen
Contact detailsGalen House
The Princess Alexandra Hospital NHS Trust
Hamstel Road

Harlow
United Kingdom
CM20 1QX
Contact telephone+44 (0)1279 694937/28
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN82960239
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central